Diabetes Flashcards
Insulin synthesis
Pre-proinsulin –> proinsulin –> insulin + cleaved C peptide
C peptide
Good indicator of Beta islets cell function. Lasts longer than insulin
Insulin
Glycogenesis
Glucagon
Glycogenolysis
T1DM
Autoimmune Beta cell destruction causing an absolute insulin deficiency - little/no insulin being produced. Therefore, increased glucose in the blood and less glucose bing stored and/or used in the organs
T1DM is associated with HLA-DR3 T/F
T1DM is associated with Human leukocyte antigen DR3 or 4. (HLA-DR3/4)
T1DM definition
A metabolic disorder characterised by high glucose levels due to absolute insulin deficiency.
- 10-20% of all diabetes
most common under age of 20yrs
peak incidence at 10-14yrs
Personal/family history of autoimmune disease e.g. Hashimoto’s - increases risk
Accute manifestation = DKA.
T1DM Symptoms
polyuria polydipsia polyphagia weight loss fatigue poor wound healing
T1DM Management
Insulin
What would you expect to see with T1DM on investigation?
Low C-peptide (tested in patients with atypical features)
High blood sugar
Investigations
- Random blood glucose: >11mmol/l with clinical features –> same day referral
- Fasting blood glucose ≥ 7.0mmol/L is typical
- OGTT >11 mmol/l two hours after a 75g oral glucose load
- HbA1c: >48 mmol/l suggests hyperglycaemia over 3 months. use for monitoring
NB: HBa1C is inaccurate in children, haemolytic anaemia and pregnancy
What investigations could you consider in T1DM
- C-peptide: if atypical features are present e.g. age > 50, BMI >25kg/m2
- Autoantibodies: if atypical features are present, e.g. anti-glutamic acid decarboxylase
- VBG: If concerned about DKA
First line management of T1DM
Basal bolus regime
Management
Urgent referral to daibetes specialist
Lifestyle
- diet high in fibre and low in fat, sugar and sal
- educate regarding carb counting, allows insulin dose to be matched to intake
Insulin therapy
- Basal bolus: 1st line, long acting regularly (basal) with rapid acting insulin before meals (bolus)
- basal - Levemir (detemir) given twice daily. Lantus (glargine) one daiy is an alternative
- bolus insulin lispro (humalog), insulin aspart (novorapid)
Mixed insulin regime - mixed insulin comprises a short acting and long acting insulin, BD.
- used when unable to tolerate basal-bolus regime
Continuous insulin infusion: Disabling hypoglycaemia or persistent hyperglycaemia (HbA1c >69mmol/mol)
Monitoring
Glucose
- HbA1c: measured every 3-6 months with a target of ≤48 mol/mol
- Selft monitoring: check blood at least 4 times a day with the following targets
on waking: 5-7mmol/L
before meals and other times 4-7mmol/L
Retinopathy
- Immediate ophthalmoogy referral upon diagnosis and annually thereafter
arrange urgent review thereafter if:
- acute reduction in acuity
- pre proliferative or proliferative retinopathy
- diabetic maculopathy
Diabetic foot
- Should be assess at least annually; refer urgently to foot protection service if at risk (e.g. ulceration)
Diabetic nephropathy
- Annual measurement of eGFR and urinary albumin:creatinine ratio